Data Foundry

Drug recalls 2026

Amlodipine and Olmesartan Medoxomil Tablets — Class II drug recall D-0045-2027

Ongoing recall by Ascend Laboratories, LLC, reported 2026-10-28, distributed nationwide. Out of specification due to dissolution.

Recall numberD-0045-2027
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmAscend Laboratories, LLC, Bedminster, NJ, United States
Recall initiated2026-10-06
Classified2026-10-16
Reported by FDA2026-10-28
DistributedNationwide (US)
Quantity11,424 bottles
Reason classesspecification failure
NDC67877-0499, 67877-0499-30, 67877-0499-90, 67877-0500, 67877-0500-30, 67877-0500-90, 67877-0501, 67877-0501-30, 67877-0501-90, 67877-0502, 67877-0502-30, 67877-0502-90
Lot numbers25120696
Expiration dates2026-12-31

Product

Amlodipine and Olmesartan Medoxomil Tablets, 10mg/40mg, 30 Tablets, Rx only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-502-30.

Reason for recall

Out of specification due to dissolution.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0045-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-11-10. Not affiliated with or endorsed by FDA. Not medical or legal advice.